Hematological, Inflammatory, Coagulation, and Oxidative/Antioxidant Biomarkers as Predictors for Severity and

Shukur Wasman Smail1, Esmaeil Babaei2,3, Kawa Amin4

  • 1Department of Biology, College of Science, Salahaddin University, Erbil, Iraq.

Insights

Predicting COVID-19 mortality is possible using routine lab tests and oxidative stress biomarkers. Key predictors include D-dimer, malondialdehyde, and neutrophil/lymphocyte ratio, indicating disease severity.

Area of Science:

  • Biochemistry
  • Immunology
  • Clinical Medicine

Background:

  • Oxidative stress and inflammation are central to COVID-19 pathophysiology.
  • Understanding predictors of COVID-19 severity and mortality is crucial for patient management.

Purpose of the Study:

  • To investigate routine laboratory and oxidative stress/antioxidative biomarkers as predictors of COVID-19 mortality.
  • To identify specific biomarkers associated with disease severity and prognosis.

Main Methods:

  • Prospective cohort study of 120 COVID-19 patients and 60 healthy controls.
  • Categorization of patients into mild, severe, and critical groups based on clinical criteria.
  • Measurement of routine laboratory biomarkers, oxidative stress markers (MDA, NO, SOD, TAC), and antioxidant levels (Vitamin C, GPx, Catalase).

Main Results:

  • Neutrophil/lymphocyte ratio (NLR), CRP, ferritin, and D-dimer were elevated in severe and critical cases.
  • Increased malondialdehyde (MDA) and nitric oxide (NO) with decreased superoxide dismutase (SOD) and total antioxidant capacity (TAC) observed.
  • D-dimer, MDA, and NLR were identified as predictors of mortality; NO and ferritin predicted ICU hospitalization.

Conclusions:

  • Immune dysregulation and oxidative imbalance are linked in COVID-19.
  • NLR, NO, ferritin, and D-dimer are potential predictors of COVID-19 severity and mortality.
  • Age over 50 is associated with a poorer prognosis in the Kurdish population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
219
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
134
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19